Literature DB >> 32803952

Conditional Deoxyribozyme-Nanoparticle Conjugates for miRNA-Triggered Gene Regulation.

Jiahui Zhang1, Rong Ma2, Aaron Blanchard1, Jessica Petree2, Hanjoong Jo1,3, Khalid Salaita1,2.   

Abstract

DNA-nanoparticle (NP) conjugates have been used to knockdown gene expression transiently and effectively, making them desirable tools for gene regulation therapy. Because DNA-NPs are constitutively active and are rapidly taken up by most cell types, they offer limited control in terms of tissue or cell type specificity. To take a step toward solving this issue, we incorporate toehold-mediated strand exchange, a versatile molecular programming modality, to switch the DNA-NPs from an inactive state to an active state in the presence of a specific RNA input. Because many transcripts are unique to cell subtype or disease state, this approach could one day lead to responsive nucleic acid therapeutics with enhanced specificity. As a proof of concept, we designed conditional deoxyribozyme-nanoparticles (conditional DzNPs) that knockdown tumor necrosis factor α (TNFα) mRNA upon miR-33 triggering. We demonstrate toehold-mediated strand exchange and restoration of TNFα DNAzyme activity in the presence of miR-33 trigger, with optimization of the preparation, configuration, and toehold length of conditional DzNPs. Our results indicate specific and strong ON/OFF response of conditional DzNPs to the miR-33 trigger in buffer. Furthermore, we demonstrate endogenous miR-33-triggered knockdown of TNFα mRNA in mouse macrophages, implying the potential of conditional gene regulation applications using these DzNPs.

Entities:  

Keywords:  DNA−NP conjugates; TNFα; conditional gene regulation; deoxyribozyme; macrophages; miR-33

Mesh:

Substances:

Year:  2020        PMID: 32803952      PMCID: PMC8287654          DOI: 10.1021/acsami.0c07609

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  51 in total

Review 1.  Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.

Authors:  Xavier Mariette; Marco Matucci-Cerinic; Karel Pavelka; Peter Taylor; Ronald van Vollenhoven; Rebecca Heatley; Claire Walsh; Richard Lawson; Alan Reynolds; Paul Emery
Journal:  Ann Rheum Dis       Date:  2011-09-01       Impact factor: 19.103

2.  Remote toehold: a mechanism for flexible control of DNA hybridization kinetics.

Authors:  Anthony J Genot; David Yu Zhang; Jonathan Bath; Andrew J Turberfield
Journal:  J Am Chem Soc       Date:  2011-01-26       Impact factor: 15.419

3.  Freezing Directed Construction of Bio/Nano Interfaces: Reagentless Conjugation, Denser Spherical Nucleic Acids, and Better Nanoflares.

Authors:  Biwu Liu; Juewen Liu
Journal:  J Am Chem Soc       Date:  2017-07-06       Impact factor: 15.419

4.  Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates.

Authors:  Chung Hang J Choi; Liangliang Hao; Suguna P Narayan; Evelyn Auyeung; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

5.  MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis.

Authors:  Mireille Ouimet; Hasini N Ediriweera; U Mahesh Gundra; Frederick J Sheedy; Bhama Ramkhelawon; Susan B Hutchison; Kaitlyn Rinehold; Coen van Solingen; Morgan D Fullerton; Katharine Cecchini; Katey J Rayner; Gregory R Steinberg; Phillip D Zamore; Edward A Fisher; P'ng Loke; Kathryn J Moore
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

6.  Antibody-linked spherical nucleic acids for cellular targeting.

Authors:  Ke Zhang; Liangliang Hao; Sarah J Hurst; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2012-09-28       Impact factor: 15.419

Review 7.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

8.  Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.

Authors:  Rong Deng; Na Shen; Yang Yang; Hongliang Yu; Shuping Xu; Ying-Wei Yang; Shujun Liu; Kamel Meguellati; Fei Yan
Journal:  Biomaterials       Date:  2018-03-14       Impact factor: 12.479

9.  Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarction.

Authors:  Inthirai Somasuntharam; Kevin Yehl; Sheridan L Carroll; Joshua T Maxwell; Mario D Martinez; Pao-Lin Che; Milton E Brown; Khalid Salaita; Michael E Davis
Journal:  Biomaterials       Date:  2015-12-21       Impact factor: 12.479

Review 10.  Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs.

Authors:  Sandeep Kumar; Chan Woo Kim; Rachel D Simmons; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.